Mood disorders in restless legs syndrome (Willis-Ekbom disease)

Journal of Clinical Psychiatry

Volumn 75, Issue 7, 2014, Pages

  Becker, Philip M ^a   Sharon, Denise ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ANXIETY; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; COMORBIDITY; DEPRESSION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG USE; EVIDENCE BASED MEDICINE; FACTORIAL ANALYSIS; HUMAN; INSOMNIA; MEDICAL RESEARCH; METHODOLOGY; MOOD DISORDER; PANIC; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PSYCHOPATHY; PSYCHOSIS; QUALITY CONTROL; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SCORING SYSTEM; SENSORY DYSFUNCTION; SLEEP DISORDER; SYMPTOM;

COMORBIDITY; HUMANS; MOOD DISORDERS; RESTLESS LEGS SYNDROME;

EID: 84905253925     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13r08692     Document Type: Review

References (131)

1. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286-1292. doi:10.101/archinte.165.1.1286 PubMed
2. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196-202. doi:10.101/archinte.164.2.196 PubMed
3. Innes KE, Selfe TK, Agarwal P. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med. 2011;12(7):623-634. doi:10.1016/j.slep.2010.12.018 PubMed
4. Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16(4):283-295. doi:10.1016/j.smrv.201.05.02 PubMed
5. Allen RP, Bharmal M, Calloway M. Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord. 2011;26(1):114-120. doi:10.102/mds.23430 PubMed
6. Allen RP, Picchietti D, Hening WA, et al; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-119. doi:10.1016/S1389-9457(03)010-8 PubMed
7. Winkelman JW. Considering the causes of RLS. Eur J Neurol. 2006;13(suppl 3):8-14. PubMed
8. Patton SM, Cho YW, Clardy TW, et al. Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease. Fluids Barriers CNS. 2013;10(1):20. doi:10.186/2045-818-10-20 PubMed
9. Ferini-Strambi L. RLS-like symptoms: differential diagnosis by history and clinical assessment. Sleep Med. 2007;8(suppl 2):S3-S6. doi:10.1016/j.slep. 207.04.09 PubMed
10. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357(7):639-647. doi:10.1056/ NEJMoa072743 PubMed
11. Winkelmann J, Czamara D, Schormair B, et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet. 2011;7(7):e1002171. doi:10.1371/journal.pgen.102171 PubMed
12. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000-1006. doi:10.1038/ng209 PubMed
13. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22(suppl 18):S440-S448. doi:10.102/mds.21607 PubMed
14. Becker PM. The biopsychosocial effects of restless legs syndrome (RLS). Neuropsychiatr Dis Treat. 2006;2(4):505-512. doi:10.2147/nedt.206.2.4.505 PubMed
15. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160(14):2137-2141. doi:10.101/archinte.160.14.2137 PubMed
16. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54(5):1064-1068. doi:10.1212/WNL.54.5.1064 PubMed
17. Ulfberg J, Bjorvatn B, Leissner L, et al; Nordic RLS Study Group. Comorbidity in restless legs syndrome among a sample of Swedish adults. Sleep Med. 2007;8(7-8):768-772. doi:10.1016/j.slep.206.1.015 PubMed
18. Ulfberg J, Nyström B, Carter N, et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16(6):1159-1163. doi:10.102/mds.1209 PubMed
19. Choi JW, Ko D, Lee GT, et al. Reduced neural synchrony in patients with restless legs syndrome during a visual oddball task. PLoS ONE. 2012;7(7):e42312. doi:10.1371/journal.pone.042312 PubMed
20. Fulda S, Beitinger ME, Reppermund S, et al. Short-term attention and verbal fluency is decreased in restless legs syndrome patients. Mov Disord. 2010;25(15):2641-2648. doi:10.102/mds.2353 PubMed
21. Fulda S, Szesny N, Ising M, et al. Further evidence for executive dysfunction in subjects with RLS from a non-clinical sample. Sleep Med. 2011;12(10):1003-1007. doi:10.1016/j.slep.201.04.013 PubMed
22. Earley CJ, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med. 2010;11(9):807-815. doi:10.1016/j.slep.2010.07.07 PubMed
23. Szentkiralyi A, Völzke H, Hoffmann W, et al. The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies. Psychosom Med. 2013;75(4):359-365. doi:10.1097/PSY.0b013e31828bf1 PubMed
24. Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008;20(1):101-105. doi:10.176/api.neuropsych.20. 1.101 PubMed
25. Agüera-Ortiz L, Perez MI, Osorio RS, et al. Prevalence and clinical correlates of restless legs syndrome among psychogeriatric patients. Int J Geriatr Psychiatry. 2011;26(12):1252-1259. doi:10.102/gps.2674 PubMed
26. Rye DB, Trotti LM. Restless legs syndrome and periodic leg movements of sleep. Neurol Clin. 2012;30(4):1137-1166. doi:10.1016/j.ncl.2012.08.04 PubMed
27. Fulda S, Kloiber S, Dose T, et al. Mirtazapine provokes periodic leg movements during sleep in young healthy men. Sleep. 2013;36(5):661-669. PubMed
28. Goerke M, Rodenbeck A, Cohrs S, et al. The influence of the tricyclic antidepressant amitriptyline on periodic limb movements during sleep. Pharmacopsychiatry. 2013;46(3):108-113. doi:10.105/s-032-131702 PubMed
29. Hoque R, Chesson AL Jr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med. 2010;6(1):79-83. PubMed
30. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry. 2005;58(6):510-514. doi:10.1016/j.biopsych. 205.04.02 PubMed
31. Zhang B, Hao Y, Jia F, et al. Sertraline and periodic limb movements during sleep: an 8-week open-label study in depressed patients with insomnia. Sleep Med. 2013;14(12):1405-1412. doi:10.1016/j.slep.2013.07.019 PubMed
32. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237-246. doi:10.1016/j.slep.204.03.06 PubMed
33. Banno K, Delaive K, Walld R, et al. Restless legs syndrome in 218 patients: associated disorders. Sleep Med. 2000;1(3):221-229. doi:10.1016/S1389-9457(0)023-X PubMed
34. Walters AS; The International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord. 1995;10(5):634-642. doi:10.102/mds.87010517 PubMed
35. International Restless Legs Syndrome Study Group. Revised IRLSSG Diagnostic Criteria for RLS. http://irlssg.org/diagnostic-criteria/. Accessed August 6, 2012.
36. Merlino G, Serafini A, Robiony F, et al. Restless legs syndrome: differential diagnosis and management with rotigotine. Neuropsychiatr Dis Treat. 2009;5:67-80. PubMed
37. Earley CJ, Allen RP, Hening W. Restless legs syndrome and periodic leg movements in sleep. Handb Clin Neurol. 2011;99:913-948. doi:10.1016/B978-0-4- 5207-4.015-1 PubMed
38. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32(5):589-597. PubMed
39. Ferini-Strambi L, Walters AS, Sica D. The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease [published online ahead of print August 21, 2013]. J Neurol. 2013. doi:10.107/s0415-013-7065-1 PubMed
40. Michaud M, Paquet J, Lavigne G, et al. Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol. 2002;48(2):108-113. doi:10.159/06296 PubMed
41. Michaud M, Lavigne G, Desautels A, et al. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord. 2002;17(1):112-115. doi:10.102/mds.104 PubMed
42. Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord. 1998;13(2):324-329. doi:10.102/mds.87013020 PubMed
43. Cho SJ, Hong JP, Hahm BJ, et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep. 2009;32(8):1069-1076. PubMed
44. Kim KW, Yoon IY, Chung S, et al. Prevalence, comorbidities and risk factors of restless legs syndrome in the Korean elderly population: results from the Korean Longitudinal Study on Health and Aging. J Sleep Res. 2010;19(1, pt 1):87-92. doi:10.1/j.1365-2869.209.0739.x PubMed
45. Kim WH, Kim BS, Kim SK, et al. Restless legs syndrome in older people: a community-based study on its prevalence and association with major depressive disorder in older Korean adults. Int J Geriatr Psychiatry. 2012;27(6):565-572. doi:10.102/gps.2754 PubMed
46. Nomura T, Inoue Y, Kusumi M, et al. Prevalence of restless legs syndrome in a rural community in Japan. Mov Disord. 2008;23(16):2363-2369. doi:10.102/mds.274 PubMed
47. Sevim S, Dogu O, Kaleagasi H, et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004;75(2):226-230. PubMed
48. Broman JE, Mallon L, Hetta J. Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden. Psychiatry Clin Neurosci. 2008;62(4):472-475. doi:10.1/j.140-1819.208.01825.x PubMed
49. Hornyak M, Kopasz M, Berger M, et al. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry. 2005;66(9):1139-1145. doi:10.408/JCP.v6n0909 PubMed
50. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7(7):545-552. doi:10.1016/j.slep.206.01.04 PubMed
51. Froese CL, Butt A, Mulgrew A, et al. Depression and sleep-related symptoms in an adult, indigenous, North American population. J Clin Sleep Med. 2008;4(4):356-361. PubMed
52. Wesstrom J, Nilsson S, Sundstrom-Poromaa I, et al. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric. 2008;11(5):422-428. doi:10.1080/13697130802359683 PubMed
53. Phillips B, Hening W, Britz P, et al. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest. 2006;129(1):76-80. doi:10.1378/chest.129.1.76 PubMed
54. Sukegawa T, Itoga M, Seno H, et al. Sleep disturbances and depression in the elderly in Japan. Psychiatry Clin Neurosci. 2003;57(3):265-270. doi:10.1046/j.140-1819.203.015.x PubMed
55. Celle S, Roche F, Kerleroux J, et al. Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study. J Gerontol A Biol Sci Med Sci. 2010;65(2):167-173. doi:10.1093/gerona/glp161 PubMed
56. Wagner ML, Walters AS, Fisher BC. Symptoms of attention-deficit/ hyperactivity disorder in adults with restless legs syndrome. Sleep. 2004;27(8):1499-1504. PubMed
57. Saletu B, Anderer P, Saletu M, et al. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med. 2002;3(suppl):S35-S42. doi:10.1016/S1389-9457(02)0147-8 PubMed
58. Winkelmann J, Prager M, Lieb R, et al. "Anxietas tibiarum": depression and anxiety disorders in patients with restless legs syndrome. J Neurol. 2005;252(1):67-71. doi:10.107/s0415-05-0604-7 PubMed
59. Brown LK, Dedrick DL, Doggett JW, et al. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med. 2005;6(5):443-450. doi:10.1016/j.slep.205.03.05 PubMed
60. Li Y, Mirzaei F, O'Reilly EJ, et al. Prospective study of restless legs syndrome and risk of depression in women. Am J Epidemiol. 2012;176(4):279-288. doi:10.1093/aje/kws016 PubMed
61. Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression? J Affect Disord. 2003;76(1-3):255-259. doi:10.1016/S0165-0327(02) 072-1 PubMed
62. Szentkiralyi A, Molnar MZ, Czira ME, et al. Association between restless legs syndrome and depression in patients with chronic kidney disease. J Psychosom Res. 2009;67(2):173-180. doi:10.1016/j.jpsychores.209.05.04 PubMed
63. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5(4):385-391. doi:10.1016/j.slep.204.01.012 PubMed
64. Jones R, Cavanna AE. The neurobiology and treatment of restless legs syndrome. Behav Neurol. 2013;26(4):283-292. PubMed
65. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6(6):337-346. doi:10.1038/nrneurol.2010.5 PubMed
66. Dailly E, Chenu F, Renard CE, et al. Dopamine, depression and antidepressants. Fundam Clin Pharmacol. 2004;18(6):601-607. doi:10.1/j.1472- 8206.204.0287.x PubMed
67. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry. 2006;59(12):1151-1159. doi:10.1016/j.biopsych.205. 09.018 PubMed
68. Yadid G, Friedman A. Dynamics of the dopaminergic system as a key component to the understanding of depression. Prog Brain Res. 2008;172:265-286. doi:10.1016/S079-6123(08)0913-8 PubMed
69. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64(3):327-337. doi:10.101/archpsyc.64.3. 327 PubMed
70. Aiken CB. Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry. 2007;68(8):1230-1236. doi:10.408/JCP.v68n0810 PubMed
71. Corrigan MH, Denahan AQ, Wright CE, et al. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety. 2000;11(2):58-65. doi:10.102/(SICI)1520-6394(20)1:2〈58:AID-DA2 PubMed
72. Waehrens J, Gerlach J. Bromocriptine and imipramine in endogenous depression: a double-blind controlled trial in out-patients. J Affect Disord. 1981;3(2):193-202. doi:10.1016/0165-0327(81)904-6 PubMed
73. Ishibashi K, Ishii K, Oda K, et al. Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457. PLoS ONE. 2011;6(3):e17723. doi:10.1371/journal.pone.01723 PubMed
74. Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord. 2011;26(suppl 3):S42-S80. doi:10.102/mds.2384 PubMed
75. Barone P, Scarzella L, Marconi R, et al; Depression/Parkinson Italian Study Group. Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. J Neurol. 2006;253(5):601-607. doi:10.107/s0415-06-067-5 PubMed
76. Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9(6):573-580. doi:10.1016/S1474-42(10)70106-X PubMed
77. Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci. 2002;252(4):185-194. doi:10.107/s0406-02-0380-7 PubMed
78. Saletu M, Anderer P, Högl B, et al. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome. J Neural Transm. 2003;110(6):611-626. doi:10.107/s0702-03-0814-z PubMed
79. Benes H, Mattern W, Peglau I, et al. Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study. J Neurol. 2011;258(6):1046-1054. doi:10.107/s0415-010-5879-7 PubMed
80. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005;28(7):891-898. PubMed
81. Durmer JS, Quraishi GH. Restless legs syndrome, periodic leg movements, and periodic limb movement disorder in children. Pediatr Clin North Am. 2011;58(3):591-620. doi:10.1016/j.pcl.201.03.05 PubMed
82. Pullen SJ, Wall CA, Angstman ER, et al. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study. J Clin Sleep Med. 2011;7(6):587-596. PubMed
83. Chervin RD, Dillon JE, Bassetti C, et al. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep. 1997;20(12):1185-1192. PubMed
84. Picchietti DL, Stevens HE. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med. 2008;9(7):770-781. doi:10.1016/j.slep.207.08.012 PubMed
85. Chervin RD, Archbold KH, Dillon JE, et al. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep. 2002;25(2):213-218. PubMed
86. Kotagal S, Silber MH. Childhood-onset restless legs syndrome. Ann Neurol. 2004;56(6):803-807. doi:10.102/ana.20292 PubMed
87. Picchietti D, Allen RP, Walters AS, et al. Restless legs syndrome: prevalence and impact in children and adolescents - the Peds REST study. Pediatrics. 2007;120(2):253-266. doi:10.1542/peds.206-2767 PubMed
88. Picchietti DL, England SJ, Walters AS, et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol. 1998;13(12):588-594. doi:10.17/08307389801301202 PubMed
89. Cortese S, Konofal E, Lecendreux M, et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep. 2005;28(8):1007-1013. PubMed
90. Konofal E, Arnulf I, Lecendreux M, et al. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol. 2005;32(5):350-351. doi:10.1016/j.pediatrneurol.204.1.07 PubMed
91. Walters AS, Mandelbaum DE, Lewin DS, et al; Dopaminergic Therapy Study Group. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatr Neurol. 2000;22(3):182-186. doi:10.1016/S087-894(9)0152-6 PubMed
92. Gao X, Lyall K, Palacios N, et al. RLS in middle aged women and attention deficit/hyperactivity disorder in their offspring. Sleep Med. 2011;12(1): 89-91. doi:10.1016/j.slep.2010.05.06 PubMed
93. Steinlechner S, Brüggemann N, Sobottka V, et al. Restless legs syndrome as a possible predictor for psychiatric disorders in parents of children with ADHD. Eur Arch Psychiatry Clin Neurosci. 2011;261(4):285-291. doi:10.107/s0406-010-0140-z PubMed
94. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53(1):547-554. doi:10.1016/S02-39(02)043-9 PubMed
95. Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2008;43(1): 70-75. doi:10.1016/j.jpsychires.208.02.06 PubMed
96. Leutgeb U, Martus P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res. 2002;7(8):368-378. PubMed
97. Byrne R, Sinha S, Chaudhuri KR. Restless legs syndrome: diagnosis and review of management options. Neuropsychiatr Dis Treat. 2006;2(2): 155-164. doi:10.2147/nedt.206.2.2.15 PubMed
98. Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35(8):1039-1062. PubMed
99. Trenkwalder C, Hening WA, Montagna P, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008;23(16):2267-2302. doi:10.102/mds.254 PubMed
100. Aurora RN, Kristo DA, Bista SR, et al. Update to the AASM Clinical Practice Guideline: "The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults: An Update for 2012: Practice Parameters With an Evidence-Based Systematic Review and Meta-Analyses." Sleep. 2012;35(8):1037. PubMed
101. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al; Therapy with Ropiunirole; Efficacy and Tolerability in RLS 1 Study Group. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75(1):92-97. PubMed
102. Walters AS, Ondo WG, Dreykluft T, et al; TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19(12):1414-1423. doi:10.102/mds.20257 PubMed
103. Ferini-Strambi L, Aarskog D, Partinen M, et al. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Med. 2008;9(8):874-881. doi:10.1016/j.slep.208.09.01 PubMed
104. Högl B, Garcia-Borreguero D, Trenkwalder C, et al. Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep Med. 2011;12(4):351-360. doi:10.1016/j.slep.2010.12.07 PubMed
105. Montagna P, Hornyak M, Ulfberg J, et al. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood. Sleep Med. 2011;12(1):34-40. doi:10.1016/j.slep.2010.08.05 PubMed
106. Hening WA, Allen RP, Ondo WG, et al; SP792 Study Group. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord. 2010;25(11):1675- 1683. doi:10.102/mds.23157 PubMed
107. Trenkwalder C, Benes H, Poewe W, et al; SP790 Study Group. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2008;7(7):595-604. doi:10.1016/S1474-42(08)7012-1 PubMed
108. Walters AS, LeBrocq C, Dhar A, et al; International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-132. doi:10.1016/S1389-9457(02)0258-7 PubMed
109. Lee DO, Ziman RB, Perkins AT, et al; XP053 Study Group. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. J Clin Sleep Med. 2011;7(3):282-292. PubMed
110. Allen RP, Ondo WG, Ball E, et al. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med. 2011;12(5):431-439. doi:10.1016/j.slep.201.03.03 PubMed
111. García-Borreguero D, Allen RP, Kohnen R, et al; International Restless Legs Syndrome Study Group. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007;8(5):520-530. doi:10.1016/j.slep. 207.03.02 PubMed
112. Högl B, García-Borreguero D, Kohnen R, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010;257(2):230-237. doi:10.107/s0415-09-529-8 PubMed
113. García-Borreguero D, Högl B, Ferini-Strambi L, et al. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks. Mov Disord. 2012;27(2):277-283. doi:10.102/mds.2489 PubMed
114. Beneš H, García-Borreguero D, Ferini-Strambi L, et al. Augmentation in the treatment of restless legs syndrome with transdermal rotigotine. Sleep Med. 2012;13(6):589-597. doi:10.1016/j.slep.201.09.016 PubMed
115. Frauscher B, Gschliesser V, Brandauer E, et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med. 2009;10(6):611-615. doi:10.1016/j.slep.208.09.07 PubMed
116. García-Borreguero D, Williams AM. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev. 2010;14(5):339-346. doi:10.1016/j.smrv. 209.1.06 PubMed
117. Bayard M, Bailey B, Acharya D, et al. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2011;24(4):422-428. doi:10.312/jabfm.201.04.10173 PubMed
118. Nofzinger EA, Fasiczka A, Berman S, et al. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry. 2000;61(11): 858-862. doi:10.408/JCP.v61n108 PubMed
119. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(2):249-260. doi:10.1016/S0278-5846(01)0262-7 PubMed
120. Shen J, Kennedy SH, Levitan RD, et al. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. J Psychiatry Neurosci. 2005;30(1):11-16. PubMed
121. Coe HV, Hong IS. Safety of low doses of quetiapine when used for insomnia. Ann Pharmacother. 2012;46(5):718-722. doi:10.1345/aph.1Q697 PubMed
122. Pinninti NR, Mago R, Townsend J, et al. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol. 2005;25(6):617-618. doi:10.1097/01.jcp.0186870.75042.25 PubMed
123. Webb J. Co-occurring akathisia and restless legs syndrome likely induced by quetiapine. J Neuropsychiatry Clin Neurosci. 2012;24(2):E46-E47. PubMed
124. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 2002;35(3):109-111. doi:10.105/s-202-31514 PubMed
125. Aggarwal S, Dodd S, Berk M. Restless leg syndrome associated with olanzapine: a case series. Curr Drug Saf. 2010;5(2):129-131. doi:10.2174/15748610790936187 PubMed
126. Kang SG, Lee HJ, Kim L. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine. J Psychopharmacol. 2009;23(5):597-601. doi:10.17/02698108091876 PubMed
127. Khalid I, Rana L, Khalid TJ, et al. Refractory restless legs syndrome likely caused by olanzapine. J Clin Sleep Med. 2009;5(1):68-69. PubMed
128. Kikukawa S. Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome. Int J Neuropsychopharmacol. 2008;11(3):439-440. doi:10.1017/S14614570708310 PubMed
129. McLean AJ. The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome. Sleep. 2004;27(5):1022. PubMed
130. Virit O, Selek S, Savas HA, et al. Improvement of restless legs syndrome and trichotillomania with aripiprazole. J Clin Pharm Ther. 2009;34(6):723-725. doi:10.1/j.1365-2710.209.01051.x PubMed
131. Novak M, Mendelssohn D, Shapiro CM, et al. Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients. Semin Dial. 2006;19(3):210-216. doi:10.1/j.1525-139X.206.0157.x PubMed